Clinical Trial Update: Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study

View source ↗

Summary

This update reports results from the Rucaparib Access Program (RAP) in Spain, summarizing clinical experience with rucaparib in patients with epithelial ovarian…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer

Drugs mentioned

• RUBRACA (RUCAPARIB)

Snippet

Sponsor: Grupo Español de Investigación en Cáncer de Ovario | Conditions: Epithelial Ovarian Cancer, Fallopian Tube Cancer | Status: COMPLETED | Results posted: 2026-03-18